Kura Oncology (KURA) Interest Coverage Ratio (2010 - 2026)
Kura Oncology (KURA) reported Interest Coverage Ratio of 234.57 for Q1 2026, down 38.49% year-over-year from 381.37 in Q1 2025, and down 141.03% quarter-over-quarter from 571.64 in Q4 2025.
Kura Oncology (KURA) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Kura Oncology (KURA) has 8 years of Interest Coverage Ratio data on file, last reported at 234.57 in Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 234.57, down 38.49% year-over-year; the trailing twelve-month figure through Mar 2026 was 13.97 (up 87.95% YoY), and the FY2025 annual result was 200.81, down 68.28% from the prior year.
- Interest Coverage Ratio fell to 234.57 in Q1 2026 per KURA's latest filing, from 571.64 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 571.64 in Q4 2025 and troughed at 234.57 in Q1 2026.
- A 3-year average of 67.6 and a median of 131.05 in 2024 frame the typical range for Interest Coverage Ratio.
- On a YoY basis, Interest Coverage Ratio climbed as much as 1471.58% in 2025 and fell as far as 43.15% in 2025.
- A 3-year view of Interest Coverage Ratio shows it stood at 41.68 in 2024, then soared by 1471.58% to 571.64 in 2025, then sank by 141.03% to 234.57 in 2026.
- Business Quant data shows KURA's Interest Coverage Ratio at 234.57 in Q1 2026, 571.64 in Q4 2025, and 187.59 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Kura Oncology | 883.44 Mn | 883.44 Mn | 18.00 Mn | -234.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -234.57 |
| Dec 31, 2025 | 571.64 |
| Sep 30, 2025 | -187.59 |
| Jun 30, 2025 | -168.11 |
| Mar 31, 2025 | -169.37 |
| Dec 31, 2024 | -41.68 |
| Sep 30, 2024 | -131.05 |
| Jun 30, 2024 | -124.21 |
| Mar 31, 2024 | -123.43 |
| Dec 31, 2014 | -0.26 |
| Sep 30, 2014 | -2.86 |
| Jun 30, 2014 | -3.19 |
| Mar 31, 2014 | -2.54 |
| Dec 31, 2013 | -4.86 |
| Sep 30, 2013 | -2.69 |
| Jun 30, 2013 | -4.22 |
| Mar 31, 2013 | -3.75 |
| Dec 31, 2012 | -6.51 |
| Sep 30, 2012 | -3.68 |
| Jun 30, 2012 | -3.93 |